Showing 181 - 200 results of 46,306 for search '(( significant ((treatment decreased) OR (greater decrease)) ) OR ( significant change decrease ))', query time: 0.70s Refine Results
  1. 181
  2. 182

    datasheet1_Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.pdf by Victor Gustavo Balera Brito (9626207)

    Published 2020
    “…The SHR + PD group showed greater alveolar bone loss than the W + PD group, what was significantly inhibited by treatment with TELM, especially in the SHR group. …”
  3. 183

    datasheet1_Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.pdf by Victor Gustavo Balera Brito (9626207)

    Published 2020
    “…The SHR + PD group showed greater alveolar bone loss than the W + PD group, what was significantly inhibited by treatment with TELM, especially in the SHR group. …”
  4. 184

    datasheet1_Telmisartan Prevents Alveolar Bone Loss by Decreasing the Expression of Osteoclasts Markers in Hypertensive Rats With Periodontal Disease.pdf by Victor Gustavo Balera Brito (9626207)

    Published 2020
    “…The SHR + PD group showed greater alveolar bone loss than the W + PD group, what was significantly inhibited by treatment with TELM, especially in the SHR group. …”
  5. 185

    Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  6. 186

    Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  7. 187
  8. 188
  9. 189
  10. 190
  11. 191
  12. 192
  13. 193

    Data for subjects with significant slopes (regional progression or recovery colour coded, non-significant regions white) for the 4 data types over the study period. by Faran Sabeti (6166766)

    Published 2023
    “…<p>The only diabetic (non-DMO) person with significant thickness changes was mf87171 (row I). Rows A, B, D and possibly G show that increasing OFA sensitivity (OFA Sens) is associated with decreasing retinal thickness (cf. …”
  14. 194
  15. 195
  16. 196
  17. 197
  18. 198
  19. 199
  20. 200